Chemical Structure (Image 01)
Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 24689-167
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 24689-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apnar Pharma Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Image 02)
This is a graph displaying the estimated probability of the initial headache response within 2 hours after the initial dose of different doses of Eletriptan (20 mg, 40 mg, 80 mg). The horizontal axis shows the time from the initial dose in hours, and the vertical axis represents the probability of the headache response.*
Figure 2 (Image 03)
Principal Display Panel (20 mg Tablet Bottle Pack)
This text provides instructions on how to store Eletriptan tablets, including the temperature range (20°C to 25°C) and permissible excursions (15°C to 30°C). It also mentions that each tablet contains 20 mg of eletriptan hydrobromide monohydrate. Additionally, the text advises to keep the tablets tightly closed, protected from light, and out of reach of children. The tablets are distributed by Apnar Pharma LP and manufactured by Beximco Pharmaceuticals Ltd., with specific addresses provided.*
Principal Display Panel (40 mg Tablet Bottle Pack)
This text provides storage instructions and dosage information for a medication containing eletriptan hydrobromide monohydrate equivalent to 40 mg eletriptan. It includes details on temperature requirements and warnings on protecting the medication from light and keeping it out of reach of children. The medication is distributed by Beximco and is manufactured by Apnar Pharma LP, Beximco Pharmaceuticals Ltd.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
